Inogen, Inc

Stage 4 · Declining · week 15

As of Oct 22, 2026, Inogen is in Stage 4, the downtrend phase, now in week 15 (since Jul 10, 2026). It closed at $7.04, 21.3% below its 52-week high and above its 200-day average, which is falling.

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. More about the company

$7.04

+5.55% today

$187M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is INGN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 17w

S2 21w

S4 18w

S4 15w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 17w → S1 13w → S2 7w → S3 3w → S2 21w → S3 12w → S2 8w → S3 2w → S4 18w → S1 10w → S2 6w → S3 6w → S4 15w → S1 12w → S4 15w current

Total tracked: 166 weeks across 15 stage runs.

INGN among Medical Devices63rd of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…63	INGNInogen, Inc	Stage 4 · wk 15	41	+38.3%

vs 52W High

-21.3%

$5.09 lo$8.95 hi

21.3% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 15

1w13w26w

Week 15, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

13.3%

200 DMA: $6.21 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.68x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+38.3%

+14.5%

+0.7%

YTD

+6.2%

-17.1%

Scan Membership

Breakout Watch

Latest: 2025-01-16

6 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 15 · Vol 1.68x

2026-10-21S4

Wk 15 · Vol 0.51x

2026-10-20S4

Wk 15 · Vol 0.74x

2026-10-19S4

Wk 15 · Vol 0.74x

2026-10-16S4

Wk 14 · Vol 0.61x

2026-10-15S4

Wk 14 · Vol 0.50x

2026-10-14S4

Wk 14 · Vol 1.09x

2026-10-13S4

Wk 14 · Vol 0.91x

2026-10-12S4

Wk 14 · Vol 0.74x

2026-10-09S4

Wk 13 · Vol 0.76x

2026-10-08S4

Wk 13 · Vol 1.45x

2026-10-07S4

Wk 13 · Vol 0.70x

Moving averages & range

50 DMA

$5.66

200 DMA

$6.21

52W High

$8.95

52W Low

$5.09

5D Low

$6.25

Resistance levels (recent highs)

20d High

$7.04

60d High

$7.04

120d High

$7.19

250d High

$8.77

Next resistance

+2.1%

to 120d High

ROE

-13.1%

Profit margin -6.9%

Dividend Yield

0.00%

P/B 1.1

Inogen: quick answers

What stage is Inogen in?

As of Oct 22, 2026, Inogen (INGN) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 10, 2026 and is in week 15. What the four stages mean

Is Inogen in an uptrend?

No. Inogen is in a Stage 4 downtrend. It trades 13.3% above its 200-day average, which is falling.

How far is Inogen from its 52-week high?

Inogen closed at $7.04 on Oct 22, 2026, 21.3% below its 52-week high of $8.95. Its 52-week low is $5.09.

How has Inogen performed over the past year?

As of Oct 22, 2026, Inogen is down 17.1% over the past year and up 6.2% so far in 2026.

Which sector and industry is Inogen in?

Inogen is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.